Experts in leveraging genetic data for generating translational insights that drive drug discovery and development forward.
"We bridge the interface between academia, clinical medicine and drug development. Our dedicated team is committed to delivering high-quality research that can be used to directly generate actionable and translatable insights for our clients and partners."
Dr. Dipender Gill
CEO, Sequoia Genetics

London, UK
White City
Founded in 2024, Sequoia Genetics is dedicated to transforming genetic data into actionable insights. Our mission is to collaborate with academia, investors, and the pharmaceutical and biotech industries to enhance drug discovery and development.
We strive to be at the forefront of innovation, driving advancements that benefit healthcare worldwide.
Learn More About Our TeamMore than 800 publications and a team H-index greater than 100, demonstrating our research excellence and commitment to advancing the field.
More about TeamAnalyses geared towards informing drug discovery and development with tangible, actionable results that drive real-world impact.
More about ClientsExpertise across clinical medicine and human biology, bridging research and practical application for better outcomes.
More about BackgroundThe common denominator for our clients is their interest in maximizing the impact of human genetic data to improve the probability of successfully developing effective therapies.
Pharmaceutical Companies
Biotechnology Firms
Investment Partners
Research Institutions
For any inquiries or to explore potential opportunities with Sequoia Genetics, please contact us. Whether you are interested in collaboration or require expert guidance.
Get in Contact